From: High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
Tumor | Sources of HMGB1 | Cellular function | Interactors and pathways | Inhibitors | References |
---|---|---|---|---|---|
MDS | DCs | Interacts with T cells to mediate DCs | RAGE | NR | [88] |
Plasma and BM | Impairs the ability of macrophages to phagocytose apoptotic cells | TLR4 | TLR4 inhibitors | [52] | |
BM | Modulates the innate immune system and inhibits apoptosis | TLRs and NF-κB pathways | HMGB1 siRNAs and sivelestat | [99] | |
AML | APL cell line NB4 | Mediates autophagy and affects the degradation of PML-RARα | ROS, p62/SQSTM and PML-RARα | NAC | [101] |
APL | Enhances inflammation and promotes ATRA/ATO-induced DS | MEK/ERK pathways | NR | [103] | |
MEL cells | Promotes MEL cells differentiation | NR | NR | [106] | |
NR | Stimulates AML cells proliferation and angiogenesis | TNF-α and Tim-3 | NR | [69] | |
AML cells | Represses apoptosis and promotes autophagy and therapeutic resistance | Beclin-1/PI3KC3, Atg5-Atg12-Atg16 | MiR-34a, MiR-181b3, MiR-142-3p | ||
THP cells | Promotes migration | MCP-1 and Mcl-1 | GL | [111] | |
Mammalian cells | Reduces adhesion | RAGE | NR | [112] | |
Extracellular | Prevents necroptosis | NF-κB pathway | NR | [114] | |
MPN | CML cells | Promotes proliferation | COX-2, Akt/surviving and Akt/ID3 pathways | Cordycepin | [115] |
Cytoplasmic | Decreases CML cells sensitivity to anticancer drugs | JNK, ERK and Beclin-1 | NR | [119] | |
CML cells | Inhibits apoptosis | Bax, Bcl-2 and ROS | HMGB1 knockdown | [115] | |
ALL | ALL cells | Promotes inflammation | TNF-α and MAPK | NR | [122] |
Upregulates autophagy and chemoresistance | Ulk1-Atg13-FIP200 complex and Beclin1 | NR | [123] | ||
T- and B-ALL cells | NR | NR | MiR-181a | [124] | |
Pyroptosis cells | Induces cytokine release and CRS | IL-6 and GSDME | NR | [125] | |
CLL | CLL cells | Differentiates monocytes into NLCs | RAGE/TLR9 | NR | [127] |
CTCL | Peripheral blood | Promotes Th2 polarization and angiogenesis | IL-4, IL-10, IL-19 and angiogenin | NR | [130] |
Extracellular | Stimulates DLBCL cell proliferation | Src/ERK pathway | EP | [137] | |
ALCLs | Extracellular | Promotes the proliferation and metastasis of lymphoid cells. | NR | GL | [139] |
MM | Extracellular | Promotes drug resistance, DNA damage repair and autophagy | NR | NR | [143] |
Nucleus and cytosol | Promotes autophagy and inhibits apoptosis | ubiquitination | LncRNA MALAT-1 | [29] | |
MM bortezomib-resistant cells | Degrades HMGB1 protein and inhibits autophagy | MEK/ERK pathway | Lycorine | [30] | |
Apoptotic MM cells | Fosters an immunogenic microenvironment and promotes antitumor immunity | NR | NR | ||
Extracellular | Acts as a thrombosis-related biomarker | NR | NR |